Sutimlimab for the Treatment of Cold Agglutinin Disease

por Berentsen, Sigbjørn
Publicado 2023

Role of Complement in Autoimmune Hemolytic Anemia

por Berentsen, Sigbjørn
Publicado 2015

New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

por Berentsen, Sigbjørn
Publicado 2020

Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy

por Berentsen, Sigbjørn, Sundic, Tatjana
Publicado 2015

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?

por Berentsen, Sigbjørn, Fattizzo, Bruno, Barcellini, Wilma
Publicado 2023

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?

por Sefland, Øystein, Randen, Ulla, Berentsen, Sigbjørn
Publicado 2019

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

por Berentsen, Sigbjørn, Beiske, Klaus, Tjønnfjord, Geir E.
Publicado 2007

Mortality in cold agglutinin disease shows seasonal pattern

por Hansen, Dennis Lund, Möller, Sören, Berentsen, Sigbjørn, Frederiksen, Henrik
Publicado 2022

Cold agglutinin disease: current challenges and future prospects

por Berentsen, Sigbjørn, Röth, Alexander, Randen, Ulla, Jilma, Bernd, Tjønnfjord, Geir E
Publicado 2019

Novel insights into the treatment of complement-mediated hemolytic anemias

por Berentsen, Sigbjørn, Hill, Anita, Hill, Quentin A., Tvedt, Tor Henrik Anderson, Michel, Marc
Publicado 2019

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study

por Fattizzo, Bruno, Michel, Marc, Zaninoni, Anna, Giannotta, Juri A., Guillet, Stephanie, Frederiksen, Henrik, Vos, Josephine M.I., Mauro, Francesca R., Jilma, Bernd, Patriarca, Andrea, Zaja, Francesco, Hill, Anita, Berentsen, Sigbjørn, Barcellini, Wilma
Publicado 2020

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results

por Röth, Alexander, Barcellini, Wilma, D’Sa, Shirley, Miyakawa, Yoshitaka, Broome, Catherine M., Michel, Marc, Kuter, David J., Jilma, Bernd, Tvedt, Tor Henrik Anderson, Weitz, Ilene C., Patel, Parija, Jiang, Xiaoyu, Reuter, Caroline, Su, Jun, Shafer, Frank, Lee, Michelle, Berentsen, Sigbjørn
Publicado 2022

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C, Yamaguchi, Masaki, Nishimura, Jun-Ichi, Vos, Josephine, Cid, Joan, Storek, Michael, Wong, Nancy, Yoo, Ronnie, Jayawardene, Deepthi, Srivastava, Shruti, Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M
Publicado 2023

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA S...

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C, Yamaguchi, Masaki, Nishimura, Jun-Ichi, Vos, Josephine, Cid, Joan, Storek, Michael, Wong, Nancy, Yoo, Ronnie, Jayawardene, Deepthi, Kralova, Katarina, Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M
Publicado 2023

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’Sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C., Yamaguchi, Masaki, Nishimura, Jun-ichi, Vos, Josephine M. I., Storek, Michael, Wong, Nancy, Patel, Parija, Jiang, Xiaoyu, Vagge, Deepthi S., Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M.
Publicado 2022